Dr Coombs discusses research that was presented at the 2021 ASH Annual Meeting and Exposition in chronic lymphocytic leukemia, including that with covalent and noncovalent BTK inhibitors, COVID-19 vaccinations, and time-limited combinations.
Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742
In episode 8 of "EHA Unplugged", Prof. Shaun McCann details the diagnostic and prognostic criteria of CLL and the correct diagnostic work-up. He also describes the increasing array of treatments available for CLL patients and outlines the role of allogeneic transplantation in this disease.What did you think of this pod... more